CSL Annual Report 2022

CSL Limited Annual Report 2021/22 53 Standing up for Ukraine CSL and its employees are saddened by the violence and devastating toll caused by the war in Ukraine and have joined the statements and initiatives to support the people and patients affected by the war. To aid with humanitarian efforts, CSL participated in Global Citizen’s Stand Up For Ukraine campaign in April 2022, under the auspices of the European Commission and governments. CSL CEO and MD, Paul Perreault, personally engaged in this initiative and stated our strong commitment to human health and human rights, and CSL pledged a donation of our life-saving medicines, for a value of more than €1.6 million to support humanitarian efforts in the region. We have worked with the European institutions and governments, and coordinated with Ukrainian authorities to deliver this donation through the European Union RescuEU program and the EU Civil Protection Mechanism to Ukraine. Our life saving medicines will help treat infected wounds, provide treatment for people exposed to hepatitis B, help control bleeds with blood-clotting therapies and treat those suffering from shock following serious injury, severe burn or surgery. In addition, we have also worked with several international organisations, such as WHO, to provide a number of our life-saving medicines. We continue in close dialogue with other international partners active in Ukraine and the region, such as Direct Relief and UNICEF, as well as European and local patient and clinician organisations, to stay close to evolving patient needs and provide access to our medicine supply network as they strengthen their overall support capabilities in the area. We also initiated an employee donation match and CSL Plasma donor campaign, raising a combined US$249,154 for several charitable organisations providing on-ground emergency relief for war-affected communities and in surrounding countries. We continue to monitor risks of the war in Ukraine and stand ready to assist where our capabilities and therapies can provide assistance. PNG expanded antivenom access – moving beyond roads, to air and the sea Now in its fourth year, the Papua New Guinea (PNG) Snakebite Partnership continues to address an important public health issue through strategic partnerships resulting in new and innovative ways to improve access to antivenoms. CSL Seqirus collaborates with the Australian High Commission in PNG, the PNG Department of Health, and the University of Melbourne to donate up to 600 vials of antivenom per year, which are distributed across PNG via trained healthcare workers. This improves the chances of timely administration of antivenom to potentially help save lives in a country with one of the highest snakebite rates in the world. During the COVID-19 pandemic, the program has found innovative ways to open up access to more remote parts of the country through collaborations with St John Ambulance on the roads of Central Province, Manolos Aviation to leverage the airspace above Lae and beyond, and the Youth with a Mission (YWAM) Medical Ship that serves communities along the southern coast of PNG. YWAMMedical Ship in PNG